BSE Live
Jul 31, 16:01Prev. Close
5.10
Open Price
5.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jul 31, 15:40Prev. Close
4.95
Open Price
5.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Vivimed Labs (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -2.31 | 0.75 | 1.20 | 15.59 | 5.02 | |
| Diluted EPS (Rs.) | -2.24 | 0.72 | 1.18 | 15.13 | 4.87 | |
| Cash EPS (Rs.) | -0.31 | 2.96 | 3.39 | 18.91 | 16.61 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 62.22 | 64.78 | 64.15 | 64.53 | 227.50 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 66.80 | 69.39 | 68.76 | 69.23 | 228.12 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.40 | 0.40 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 33.36 | 30.51 | 31.67 | 70.33 | 197.11 | |
| PBDIT/Share (Rs.) | 4.68 | 9.18 | 9.55 | 31.97 | 53.19 | |
| PBIT/Share (Rs.) | 2.68 | 6.97 | 7.35 | 28.66 | 41.59 | |
| PBT/Share (Rs.) | -2.50 | 0.62 | 1.07 | 21.40 | 7.00 | |
| Net Profit/Share (Rs.) | -2.31 | 0.75 | 1.20 | 15.59 | 5.02 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 14.03 | 30.09 | 30.14 | 45.46 | 26.98 | |
| PBIT Margin (%) | 8.04 | 22.84 | 23.20 | 40.75 | 21.10 | |
| PBT Margin (%) | -7.49 | 2.03 | 3.38 | 30.42 | 3.55 | |
| Net Profit Margin (%) | -6.93 | 2.45 | 3.77 | 22.17 | 2.54 | |
| Return on Networth / Equity (%) | -3.71 | 1.15 | 1.86 | 24.16 | 2.20 | |
| Return on Capital Employed (%) | 2.90 | 7.05 | 7.08 | 27.08 | 0.88 | |
| Return on Assets (%) | -1.79 | 0.53 | 0.78 | 9.28 | 0.59 | |
| Total Debt/Equity (X) | 0.49 | 0.57 | 0.71 | 0.94 | 1.32 | |
| Asset Turnover Ratio (%) | 25.91 | 21.80 | 20.82 | 41.88 | 23.39 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.84 | 1.84 | 1.64 | 1.55 | 1.59 | |
| Quick Ratio (X) | 0.96 | 1.00 | 0.91 | 0.99 | 0.99 | |
| Inventory Turnover Ratio (X) | 1.05 | 0.89 | 0.89 | 1.99 | 1.19 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 40.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 14.09 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 60.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 85.91 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 304.45 | 471.99 | 951.82 | 1,340.92 | 1,151.36 | |
| EV/Net Operating Revenue (X) | 1.10 | 1.87 | 3.64 | 2.35 | 3.60 | |
| EV/EBITDA (X) | 7.84 | 6.23 | 12.08 | 5.18 | 13.36 | |
| MarketCap/Net Operating Revenue (X) | 0.22 | 0.77 | 2.24 | 1.51 | 2.11 | |
| Retention Ratios (%) | 0.00 | 0.00 | 59.99 | 0.00 | 0.00 | |
| Price/BV (X) | 0.12 | 0.36 | 1.11 | 1.65 | 1.83 | |
| Price/Net Operating Revenue | 0.22 | 0.77 | 2.24 | 1.51 | 2.11 | |
| Earnings Yield | -0.32 | 0.03 | 0.02 | 0.15 | 0.01 |
14.11.2025
Vivimed Labs Consolidated September 2025 Net Sales at Rs 20.61 crore, down 16.79% Y-o-Y
14.11.2025
Vivimed Labs Standalone September 2025 Net Sales at Rs 18.66 crore, down 15.8% Y-o-Y
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y
14.11.2025
Vivimed Labs Consolidated September 2025 Net Sales at Rs 20.61 crore, down 16.79% Y-o-Y
14.11.2025
Vivimed Labs Standalone September 2025 Net Sales at Rs 18.66 crore, down 15.8% Y-o-Y
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y